JP2023553014A5 - - Google Patents
Info
- Publication number
- JP2023553014A5 JP2023553014A5 JP2023534100A JP2023534100A JP2023553014A5 JP 2023553014 A5 JP2023553014 A5 JP 2023553014A5 JP 2023534100 A JP2023534100 A JP 2023534100A JP 2023534100 A JP2023534100 A JP 2023534100A JP 2023553014 A5 JP2023553014 A5 JP 2023553014A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- epitope
- coding nucleic
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121164P | 2020-12-03 | 2020-12-03 | |
| US63/121,164 | 2020-12-03 | ||
| PCT/US2021/061876 WO2022120217A2 (en) | 2020-12-03 | 2021-12-03 | Homologous adenoviral vaccination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553014A JP2023553014A (ja) | 2023-12-20 |
| JP2023553014A5 true JP2023553014A5 (https=) | 2024-12-10 |
Family
ID=81854908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534100A Pending JP2023553014A (ja) | 2020-12-03 | 2021-12-03 | 同種アデノウイルスワクチン接種の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240093235A1 (https=) |
| EP (1) | EP4255477A4 (https=) |
| JP (1) | JP2023553014A (https=) |
| KR (1) | KR20230117163A (https=) |
| CN (1) | CN116669760A (https=) |
| AU (1) | AU2021391921A1 (https=) |
| CA (1) | CA3200935A1 (https=) |
| IL (1) | IL303298A (https=) |
| WO (1) | WO2022120217A2 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040136963A1 (en) * | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
| AU2019275072A1 (en) * | 2018-05-23 | 2021-01-21 | Seattle Project Corp. | Shared antigens |
| BR112021010611A2 (pt) * | 2018-12-14 | 2021-08-24 | Glaxosmithkline Biologicals S.A. | Composições e métodos de vacina de reforço (prime boost) heterólogo |
| WO2021092095A1 (en) * | 2019-11-04 | 2021-05-14 | Gritstone Oncology, Inc. | Neoantigen vaccine therapy |
-
2021
- 2021-12-03 EP EP21901562.5A patent/EP4255477A4/en active Pending
- 2021-12-03 AU AU2021391921A patent/AU2021391921A1/en active Pending
- 2021-12-03 US US18/272,087 patent/US20240093235A1/en active Pending
- 2021-12-03 CN CN202180081878.0A patent/CN116669760A/zh active Pending
- 2021-12-03 KR KR1020237021567A patent/KR20230117163A/ko active Pending
- 2021-12-03 JP JP2023534100A patent/JP2023553014A/ja active Pending
- 2021-12-03 WO PCT/US2021/061876 patent/WO2022120217A2/en not_active Ceased
- 2021-12-03 IL IL303298A patent/IL303298A/en unknown
- 2021-12-03 CA CA3200935A patent/CA3200935A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541108A5 (https=) | ||
| JP7554119B2 (ja) | 共有抗原 | |
| JP2022512912A5 (https=) | ||
| JP2021525076A5 (https=) | ||
| JP2023526495A5 (https=) | ||
| US20250270589A1 (en) | Viral delivery of neoantigens | |
| US20250025544A1 (en) | Immune checkpoint inhibitor co-expression vectors | |
| JP2022512912A (ja) | アルファウイルス新生抗原ベクター及びインターフェロン阻害因子 | |
| JP2021524247A5 (https=) | ||
| JP2020518648A (ja) | アルファウイルス新生抗原ベクター | |
| JP2022534282A5 (https=) | ||
| JP2022539417A5 (https=) | ||
| JP2023521662A5 (https=) | ||
| JP2025157393A (ja) | Ｈｉｖ抗原及びｍｈｃ複合体 | |
| JP2023523413A5 (https=) | ||
| JP2020532287A (ja) | 癌の治療のためのネオアンチゲンワクチン組成物 | |
| JP2023521662A (ja) | 感染症抗原及びワクチン | |
| KR20240070547A (ko) | Kras 신생항원 요법 | |
| WO2022159511A2 (en) | Modified alphavirus vectors | |
| CN116814566A (zh) | 树突状细胞靶向的类病毒体dvlp及其制备方法和应用 | |
| JP2023553014A5 (https=) | ||
| KR20240099144A (ko) | 신생항원 보조 및 유지 요법 | |
| JP2025534300A (ja) | Ｃｔａワクチンカセット | |
| CN118302188A (zh) | 新抗原辅助和维持治疗 |